Page last updated: 2024-09-03

olmesartan medoxomil and Embryopathies

olmesartan medoxomil has been researched along with Embryopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Celentano, C; di Vera, E; Gallo, DP; Iannicco, A; Liberati, M; Prefumo, F	1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Embryopathies

Article	Year
Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Diuretics; Female; Fetal Diseases; Furosemide; Gestational Age; Humans; Imidazoles; Infant, Newborn; Male; Maternal Exposure; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Prenatal Diagnosis; Recovery of Function; Renal Insufficiency; Tetrazoles; Treatment Outcome	2008

Article

Year

Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.

Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Diuretics; Female; Fetal Diseases; Furosemide; Gestational Age; Humans; Imidazoles; Infant, Newborn; Male; Maternal Exposure; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Prenatal Diagnosis; Recovery of Function; Renal Insufficiency; Tetrazoles; Treatment Outcome

2008